Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | DNA (cytosine-5-)-methyltransferase 1 | Starlite/ChEMBL | No references |
Homo sapiens | prolyl 4-hydroxylase, beta polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | protein disulfide-isomerase | prolyl 4-hydroxylase, beta polypeptide | 508 aa | 478 aa | 21.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | hypothetical protein | 0.0102 | 1 | 1 |
Schistosoma mansoni | cpg binding protein | 0.004 | 0.342 | 0.8365 |
Schistosoma mansoni | disco-interacting protein 2 (dip2) | 0.0047 | 0.4066 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.4066 | 1 |
Trypanosoma brucei | cytosine-specific DNA methylase, putative | 0.0024 | 0.1649 | 1 |
Echinococcus multilocularis | disco interacting protein 2 | 0.0047 | 0.4066 | 1 |
Schistosoma mansoni | DNA (cytosine-5)-methyltransferase | 0.0024 | 0.1649 | 0.388 |
Giardia lamblia | Protein disulfide isomerase PDI2 | 0.0009 | 0.0117 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.004 | 0.342 | 0.8365 |
Echinococcus multilocularis | cpg binding protein | 0.004 | 0.342 | 0.8365 |
Leishmania major | modification methylase-like protein | 0.0024 | 0.1649 | 1 |
Toxoplasma gondii | C-5 cytosine-specific DNA methylase superfamily protein | 0.0024 | 0.1649 | 0.155 |
Entamoeba histolytica | DNA (cytosine-5)-methyltransferase, putative | 0.0024 | 0.1649 | 1 |
Schistosoma mansoni | cpg binding protein | 0.004 | 0.342 | 0.8365 |
Loa Loa (eye worm) | protein disulfide isomerase | 0.0009 | 0.0117 | 0.0289 |
Echinococcus granulosus | disco interacting protein 2 | 0.0047 | 0.4066 | 1 |
Plasmodium falciparum | DNA (cytosine-5)-methyltransferase | 0.0024 | 0.1649 | 0.155 |
Trypanosoma cruzi | bloodstream- specific protein 2 precursor | 0.0009 | 0.0117 | 0.5 |
Trichomonas vaginalis | protein disulfide isomerase, putative | 0.0009 | 0.0117 | 1 |
Echinococcus multilocularis | DNA methyltransferase 2, putative | 0.0024 | 0.1649 | 0.388 |
Echinococcus granulosus | cpg binding protein | 0.004 | 0.342 | 0.8365 |
Echinococcus granulosus | DNA methyltransferase 2, putative | 0.0024 | 0.1649 | 0.388 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.004 | 0.342 | 0.8412 |
Brugia malayi | Disco-interacting protein 2 homolog | 0.0047 | 0.4066 | 1 |
Plasmodium vivax | DNA (cytosine-5)-methyltransferase, putative | 0.0024 | 0.1649 | 1 |
Loa Loa (eye worm) | transglutaminase | 0.0009 | 0.0117 | 0.0289 |
Onchocerca volvulus | 0.0047 | 0.4066 | 1 | |
Trichomonas vaginalis | protein disulfide isomerase, putative | 0.0009 | 0.0117 | 1 |
Toxoplasma gondii | DNA methyltransferase 2, putative | 0.0024 | 0.1649 | 0.155 |
Loa Loa (eye worm) | Pdia4 protein | 0.0009 | 0.0117 | 0.0289 |
Brugia malayi | CXXC zinc finger family protein | 0.004 | 0.342 | 0.8365 |
Trichomonas vaginalis | protein disulfide isomerase, putative | 0.0009 | 0.0117 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 8.03 uM | PUBCHEM_BIOASSAY: Turbidimetric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
AC50 (functional) | 8.03 uM | PubChem BioAssay. Turbidimetric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | = 6.06 uM | PUBCHEM_BIOASSAY: Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.